Clinical Trials Imaging Market 2015 - Global Forecasts to 2020 - CT, MRI, PET, Ultrasound, Echocardiography & X-rays

Dublin, Oct. 05, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/wp9jft/clinical_trials) has announced the addition of the "Clinical Trials Imaging Market by Modality (CT, MRI, PET, Ultrasound, Echocardiography, X-rays), End User (Pharmaceutical Companies, CROs Medical device Manufacturers), Product (Services, software), and Region - Global Forecast to 2020" report to their offering.

Clinical imaging is the technique and process used to create images of the human body for clinical purposes to reveal, diagnose or examine diseases including study of normal anatomy and physiology. Clinical trials imaging use has rapidly increased in all phases of the clinical trial. This market report studies the potential of services, and software for diagnostic imaging and research and development.

The major drivers for the market include the growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs are driving the growth of the clinical trials imaging market. On the other hand high implementation cost of imaging systems are the major factors restraining the growth of this market.

This report segments the global market by product, modality, end-user, and geography. By product, the market includes services & software. The services segment is further divided into operational imaging services, systems & technology, reader services & design consulting. The modality segment includes CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The end-user segments included in this report are pharmaceutical companies, biotechnology companies, medical device companies/manufacturers, CROs & academic and government research institutes.

Geographic analysis reveals that North America accounted for the largest share of the global clinical trials imaging market in 2015. Growth in this market can be attributed to the increase in growth of pharmaceutical & biotechnology companies. The Asian regional segment, on the other hand, is expected to register a double-digit growth from 2015 to 2020, owing to the expansion of leading companies and increased R&D spending. R&D spending in Asia increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. The R&D spending in Asia accounted for 27.13% of global R&D expenditure in 2010.

The major players in this market include BioClinica, Inc. (U.S.), Biomedical Systems (U.S.), Cardiovascular Imaging Technologies (U.S.), ICON Public Limited Company (Ireland), Intrinsic Imaging, LLC (U.S.), IXICO, PLC (U.K.), PAREXEL International Corporation (U.S.), Radiant Sage, LLC (U.S.), VirtualScopic, Inc. (U.S.), and WorldCare Clinical, LLC (U.S.).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Clinical Trials Imaging Market, By Product

7 Clinical Trials Imaging Market, By Modality

8 Clinical Trials Imaging Market, By End User

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles

- Bioclinica, Inc.
- Biomedical Systems Corporation
- Cardiovascular Imaging Technologies, LLC
- Icon Public Limited Company
- Intrinsic Imaging LLC
- Ixico PLC
- Parexel International Corporation
- Radiant Sage LLC
- Virtualscopics, Inc.
- Worldcare Clinical, LLC

For more information visit http://www.researchandmarkets.com/research/wp9jft/clinical_trials